Novel Mutations in the Human HPRT Gene

2011 ◽  
Vol 30 (6) ◽  
pp. 440-445 ◽  
Author(s):  
Khue Vu Nguyen ◽  
Robert K. Naviaux ◽  
Kacie K. Paik ◽  
William L. Nyhan
2013 ◽  
Vol 32 (3) ◽  
pp. 155-160 ◽  
Author(s):  
Khue Vu Nguyen ◽  
William L. Nyhan

1991 ◽  
Vol 11 (8) ◽  
pp. 4157-4164
Author(s):  
D E Rincón-Limas ◽  
D A Krueger ◽  
P I Patel

The enzyme hypoxanthine phosphoribosyltransferase (HPRT) catalyzes the metabolic salvage of the purine bases hypoxanthine and guanine. We previously characterized the genomic structure of the human HPRT gene and described its promoter sequence. In this report, we identify cis-acting transcriptional control regions of the human HPRT gene by linking various 5'-flanking sequences to the bacterial chloramphenicol acetyltransferase gene. The sequence from positions -219 to -122 relative to the translation initiation site is required for maximal expression of this gene, and it functions equally in both normal and reverse orientations. In addition, a cis-acting negative element is present in the region spanning from positions -570 to -388. This negative element can also repress promoters of heterologous genes, such as those of adenosine deaminase and dihydrofolate reductase, which are structurally and functionally similar to the human HPRT promoter. Furthermore, this repressor element functions independently of its orientation but appears to be distance dependent. In vivo competition assays demonstrated that the trans-acting factor(s) that binds to this negative element specifically inhibits human HPRT promoter activity. Taken together, these data localize cis-acting sequences important in the regulation of human HPRT gene expression and should allow the study of protein-DNA interactions which modulate the transcription of this gene.


1992 ◽  
Vol 20 (2) ◽  
pp. 89-95 ◽  
Author(s):  
Björn Andersson ◽  
Sai-Mei Hou ◽  
Bo Lambert
Keyword(s):  

1997 ◽  
Vol 25 (1) ◽  
pp. 136-137 ◽  
Author(s):  
N. F. Cariello ◽  
G. R. Douglas ◽  
M. J. Dycaico ◽  
N. J. Gorelick ◽  
G. S. Provost ◽  
...  
Keyword(s):  
P53 Gene ◽  

1998 ◽  
Vol 411 (3) ◽  
pp. 179-214 ◽  
Author(s):  
J.Patrick O'Neill ◽  
Peter K Rogan ◽  
Neal Cariello ◽  
Janice A Nicklas

1995 ◽  
Vol 36 (3) ◽  
pp. 185-195 ◽  
Author(s):  
YASUHIRO KAGAWA ◽  
FUMIO YATAGAI ◽  
MASAO SUZUKI ◽  
YOUKO KASE ◽  
AKIKO KOBAYASHI ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Mohammed Alanazi ◽  
Abdulrahman Saud Al-Arfaj ◽  
Zainularifeen Abduljaleel ◽  
Hussein Fahad Al-Arfaj ◽  
Narasimha Reddy Parine ◽  
...  

Over the past decade, a steady increase in the incidence of HPRT-related hyperuricemia (HRH) has been observed in Saudi Arabia. We examined all the nine exons of HPRT gene for mutations in ten biochemically confirmed hyperuricemia patients, including one female and three normal controls. In all, we identified 13 novel mutations in Saudi Arabian HPRT-related hyperuricemia patients manifesting different levels of uric acid. The Lys103Met alteration was highly recurrent and was observed in 50% of the cases, while Ala160Thr and Lys158Asn substitutions were found in two patients. Moreover, in 70% of the patients ≥2 mutations were detected concurrently in the HPRT gene. Interestingly, one of the patients that harbored Lys103Met substitution along with two frameshift mutations at codons 85 and 160 resulting in shortened protein demonstrated unusually high serum uric acid level of 738 μmol/L. Two of the seven point mutations that resulted in amino acid change (Lys103Met and Val160Gly) were predicted to be damaging by SIFT and Polyphen and were further analyzed for their protein stability and function by molecular dynamics simulation. The identified novel mutations in the HPRT gene may prove useful in the prenatal diagnosis and genetic counseling.


Sign in / Sign up

Export Citation Format

Share Document